接骨木莓 Elderberry × 一般感冒

結論:證據分歧

The evidence base for elderberry and the common cold is small (only about 5 RCTs total) and internally contradictory.

C 🟠 C 薄弱證據 證據分歧 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 ⚠️ COI(產業聯盟資助) 🇹🇼 台灣在地警示

The evidence base for elderberry and the common cold is small (only about 5 RCTs total) and internally contradictory. The positive signal rests largely on Tiralongo 2016, whose cold-duration benefit was derived from only 29 cold cases and was industry-funded (Sambucol manufacturer linkage), and the Hawkins 2019 meta-analysis, which pooled just 180 participants across four weak trials and mixed common cold with influenza endpoints. Against this, the non-industry-funded Macknin 2020 RCT was a clear null, and the 2021 NIH-funded systematic review concluded elderberry likely does not prevent colds and that any duration benefit is uncertain. Authoritative bodies are divided to skeptical (Cleveland Clinic explicitly says there is no reason to take it; Mayo, Harvard, CDC and NCCIH all flag low-quality or uncertain evidence). A grade B as assigned by Examine overstates a body of evidence that is small, heterogeneous, partly conflicted by funding bias, and contradicted by the best-conducted independent trial; a grade C (evidence exists but small, inconsistent and uncertain) is the honest independent grade.

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.41
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
C · 證據分歧
信心度
72%
證據方向大致一致
證據層級
E2
多篇高品質統合分析(≥2 篇一致)

各層「支持此療效」的程度

分數越低=該層越不支持
L5 臨床機構權威立場
0.34
L2 PubMed原始文獻
0.45
L3 機轉生理合理性
0.45
L1 Examine國際基準
0.50
L11 AI 複核獨立判讀
0.50
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.412
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 1 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Elderberry Supplementation Reduces Cold Duration and Symptoms in Air-Travellers: A Randomized, Double-Blind Placebo-Controlled Clinical Trial
PMID: 27023596 2016 RCT (double-blind) n = 312
結論:No significant difference in cold incidence (12 elderberry vs 17 placebo, p=0.4). Among the 29 travellers who did develop a cold, the placebo group had significantly longer total cold-episode days (117 vs 57, p=0.02) and higher cumulative symptom score (583 vs 247, p=0.05).
⚠️ 廠商資助 效應量:Cold-episode days 57 vs 117 (placebo); symptom score 247 vs 583 (placebo)
前往 PubMed
Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: A meta-analysis of randomized, controlled clinical trials
PMID: 30670267 2019 統合分析 n = 180
結論:Pooling 4 RCTs (180 participants), elderberry supplementation at symptom onset substantially reduced overall upper-respiratory symptom duration versus control, with a large mean effect size (~1.7); the effect was larger in influenza than in common cold.
效應量:Large standardized mean effect (~1.7) for symptom-duration reduction
前往 PubMed
Elderberry Extract Outpatient Influenza Treatment for Emergency Room Patients Ages 5 and Above: a Randomized, Double-Blind, Placebo-Controlled Trial
PMID: 32929634 2020 RCT (double-blind) n = 87
結論:No statistically significant difference: symptom improvement 5.3 days (elderberry) vs 4.9 days (placebo); complete resolution 8.6 vs 8.7 days. Authors concluded there was no evidence elderberry benefits influenza duration or severity, contradicting earlier positive trials.
學術資助 效應量:No significant difference (null)
前往 PubMed
Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review
PMID: 33827515 2021 系統性回顧
結論:Across 5 RCTs, elderberry may not reduce the risk of developing a common cold; it may reduce cold duration and symptom severity but the evidence is uncertain. Overall quality of evidence on both benefits and harms is judged uncertain.
政府資助 效應量:Direction favourable for duration/severity; uncertain
前往 PubMed

L4a US FDA
謹慎
ELDER FLOWERS, EXTRACT (SAMBUCUS CANADENSIS L. OR SAMBUCUS NIGRA L.) — 21 CFR 182.20 — FLAVOR ENHANCER, FLAVORING AGENT OR ADJUVANT 來源↗
L4b EU EFSA
中性
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
中性
接骨木莓(Sambucus nigra)果實得供食品使用;惟接骨木之葉、莖、樹皮、未成熟果實及種子含氰苷成分,不得供食品使用。 來源↗
L4e WHO
未表態
Although no controlled clinical data are available, the descriptions in pharmacopoeias and traditional systems of medicine justify the use of Flos Sambuci as a diaphoretic for treatment of fever and chills, and as an expectorant for treatment of mild inflammation of the upper respiratory tract; also for symptomatic treatment of the common cold. 來源↗

L5a NIH Office of Dietary Supplements
謹慎
L5b Mayo Clinic
謹慎
Some research suggests that elderberry can shorten the length of the common cold by about two days and reduce the severity of cold symptoms. However, more research is needed to determine if these nonprescription remedies can ease cold symptoms. 來源↗
L5c Cleveland Clinic
反對
L5d Harvard Health
謹慎
L5e Specialty Society (condition-mapped)
謹慎

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 極高
📍立場總覽

PTT/Dcard/Mobile01 幾乎沒有「接骨木莓 x 一般感冒」的原生討論串;站內搜尋只回傳泛保健食品(蔓越莓、益生菌、葉黃素、魚油)或泛免疫話題,未見接骨木莓專題經驗文。相關搜尋結果幾乎全被業配/affiliate 排名站(樂活選物、健康醫學院、良醫健康網、痞客邦、品牌部落格)佔據,這些站常掛「PTT/Dcard 推薦品牌」字樣行銷,並非真實鄉民共識。屬冷門社群題材,業配污染高。

💬社群實感

無共識(缺乏原生社群討論,搜尋結果以業配排名文為主而非鄉民實測心得)

破解迷思 社群最常見的 3 個誤解
迷思接骨木莓可以「治療」感冒、縮短病程
事實業配/affiliate 文常如此宣稱,但對一般感冒的人體實證薄弱且不一致,並非確立療效
迷思接骨木莓能「增強免疫力預防感冒」
事實多為行銷話術,缺乏可信因果證據
迷思誤把可生食一般莓果的習慣套用到接骨木
事實生食或未煮熟的接骨木果實/葉莖含氰苷,可能噁心、嘔吐、腹瀉

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

Sambucol 接骨木軟糖,30 粒裝

代表來源 ↗
L10b · TFDA 法定身份 官方認定
🍽️一般食品

食品之標示、宣傳或廣告,不得有不實、誇張或易生誤解之情形。食品不得為醫療效能之標示、宣傳或廣告。

來源 ↗

  • 症狀緩解與支持性照護(休息、補充水分)
  • 預防措施(勤洗手等物理防護、流感疫苗)
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v25 engine_version: v1.0 claim_id: CLM-COND-common-cold-INT-elderberry-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-common-cold-INT-elderberry-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "接骨木莓能改善一般感冒",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 2,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟠 C 薄弱證據"
  }
}